Prevalence and outcomes of DKA in type 1 and type 2 DM patients treated and not treated with SGLT-2 inhibitors. Shacham EC, Sharif S, Tatoor R, Ayalon S, et al. Diabet Med 2026;43:e70237.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shacham EC, Sharif S, Tatoor R, Ayalon S, et al. Prevalence and outcomes of DKA in type 1 and type 2 DM patients treated and not treated with SGLT-2 inhibitors. Diabet Med 2026;43:e70237.
PMID: 41673901